Central China Fuwai Hospital of Zhengzhou University
9
4
4
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial Fibrillation
Role: collaborator
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Role: collaborator
Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation
Role: lead
Computed Tomography-derived Fractional Flow Reserve vs. Angiographic Quantitative Flow Ratio in Management of Patients With Coronary Artery Disease
Role: collaborator
Improving the Quality of Coronary Artery Bypass Grafting
Role: collaborator
Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease
Role: lead
Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus
Role: collaborator
Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical Trial
Role: collaborator
Development and Validation of a cCTA and Biomarker Based Risk Model for Coronary Revascularization in Elderly Patients With Coronary Artery Disease
Role: collaborator
All 9 trials loaded